CVS Health Analyst Price Targets

CVS Health Corp

CVSNYSE

$96.74

-0.46-0.47%

al cierre: Sep 4, 5:00 PM EST

$97.00

0.260.27%

After hour: 5:16 PM EST

Wall Street analyst price targets and consensus rating for CVS Health (CVS).

Price Target Range — 8 Quarters

Analyst Consensus — 20 Analysts

20Buy

Consensus RatingBuy# Analysts20Avg. Consensus PT$104Upside to Avg. PT+7.0%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 3, 2026	UBS	Kevin Caliendo	PT Cut	Buy	$126→$118
Aug 19, 2026	Argus Research	Steve Silver	PT Raise	Buy	$104→$114
Aug 12, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$111→$118
Aug 6, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$122→$126
Aug 6, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	Outperform	$130→$125
Aug 6, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$106→$108
Jul 24, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$115→$122
Jul 14, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$108→$118
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$103→$123
Jul 9, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$107→$113
Jul 7, 2026	Cantor Fitzgerald	Sarah James	PT Raise	Overweight	$100→$110
Jun 23, 2026	B of A Securities	Allen Lutz	PT Raise	Buy	$100→$110
Jun 8, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$110→$115
Jun 4, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$106→$111
Jun 1, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$102→$108
May 26, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$101→$106
May 20, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$102→$110
May 14, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$93→$106
May 13, 2026	Bernstein	Lance Wilkes	PT Raise	Outperform	$94→$106
May 12, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$101→$111